What is the appropriate management of digoxin toxicity?

Management of Digoxin Toxicity

For life-threatening digoxin toxicity (ventricular arrhythmias, progressive bradyarrhythmias, heart block, or hyperkalemia >6 mmol/L), immediately administer digoxin-specific antibody fragments (digoxin-Fab), which resolves dysrhythmias in 30-45 minutes with 50-90% response rates. 1

Immediate Assessment and Discontinuation

• Stop digoxin immediately and correct contributing factors including electrolyte disturbances (hypokalemia, hypomagnesemia, hypercalcemia) and review concurrent medications 2
• Assess for life-threatening manifestations: ventricular tachycardia/fibrillation, progressive bradyarrhythmias, third-degree heart block, or serum potassium >6 mmol/L 2
• Recognize that toxicity can occur even with therapeutic digoxin levels (0.8-2.0 ng/mL) when electrolyte abnormalities are present, particularly hypokalemia or hypomagnesemia 2

Digoxin-Specific Antibody Fragment (Digoxin-Fab) Administration

Indications for Digoxin-Fab

• Life-threatening ventricular arrhythmias (ventricular tachycardia or fibrillation) 1, 2
• Progressive bradyarrhythmias or heart block causing hemodynamic instability 1, 2
• Hyperkalemia >6 mmol/L in the setting of digoxin toxicity 3
• Massive overdose: >10 mg ingestion in adults, >4 mg in children, or serum concentration >10 ng/mL 2

Dosing Strategy

For acute poisoning with imminent cardiac arrest: Consider 80 mg bolus of digoxin-Fab, repeated as needed based on clinical response, rather than full calculated neutralizing doses 3

For chronic toxicity: Administer 40 mg (1 vial) at a time, repeating after 60 minutes if symptoms persist; most patients require 40-120 mg total (1-3 vials) 3

• Full neutralizing dose calculations often overestimate requirements and are unnecessarily expensive 3
• Clinical response typically occurs within 30-45 minutes, with free digoxin concentration falling to near zero within minutes 1, 3

Management of Specific Arrhythmias

Symptomatic Bradyarrhythmias or Heart Block

• Atropine may be reasonable as temporizing therapy while awaiting digoxin-Fab effect 1, 2
• Temporary cardiac pacing may be reasonable but carries 36% complication rate and should be reserved for cases where immunotherapy is delayed 1
• Asymptomatic bradycardia requires only temporary drug withdrawal and cardiac monitoring 2

Ventricular Arrhythmias

• Prioritize digoxin-Fab administration as definitive treatment 2
• Lidocaine or phenytoin may be reasonable as temporizing measures until digoxin-Fab can be given 1
• Correct underlying hypokalemia or hypomagnesemia 2

Electrolyte Management

Potassium Replacement

• Maintain serum potassium between 4.0-5.5 mmol/L in most cases 2
• Administer potassium orally when possible; use IV cautiously with continuous ECG monitoring for peaked T waves 2

Critical Caveat on Potassium

Do NOT give potassium in the following scenarios: 2

• Bradycardia or heart block (unless primarily from supraventricular tachycardia)
• Massive digitalis overdose with hyperkalemia
• Hyperkalemia from massive intoxication represents intracellular-to-extracellular potassium shift and is best treated with digoxin-Fab; glucose and insulin may be needed if acutely life-threatening 2

Gastrointestinal Decontamination (Acute Overdose Only)

• Activated charcoal in large doses to prevent absorption and bind digoxin during enterohepatic recirculation 2
• Gastric lavage or emesis only if ingestion occurred within 30 minutes and patient is alert 2
• Avoid gastric manipulation if >2 hours post-ingestion or toxic manifestations present, as vagal stimulation can worsen arrhythmias 2

Ineffective Treatments

Do NOT use hemodialysis, hemofiltration, hemoperfusion, or plasmapheresis - digoxin's large volume of distribution (5-10 L/kg) prevents effective extracorporeal removal 1, 2

Monitoring and Follow-Up

• Continue cardiac monitoring after digoxin-Fab administration due to small risk of rebound toxicity from redistribution 4
• Monitor serum potassium closely, as levels may drop rapidly after digoxin-Fab reverses the intracellular-to-extracellular shift 3
• Assess renal function and electrolytes periodically, as impaired renal function prolongs both digoxin (half-life >100 hours) and digoxin-Fab elimination 2, 3
• Note that 14% of patients receive digoxin after digoxin-Fab administration, representing a potential management error 5

Key Pitfalls to Avoid

• Do not delay digoxin-Fab for calculated dosing in life-threatening toxicity; clinical presentation trumps serum levels 6, 7
• Do not administer potassium blindly in bradycardia or massive overdose with hyperkalemia 2
• Do not use electrical cardioversion without reducing energy to lowest possible level if digoxin toxicity suspected 2
• Do not restart digoxin without reassessing indication, correcting precipitating factors, and considering dose reduction 4